<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2D8E82C0-85D1-4809-90FC-4716F4AF5865"><gtr:id>2D8E82C0-85D1-4809-90FC-4716F4AF5865</gtr:id><gtr:name>Institute of Food Research</gtr:name><gtr:department>Contracts</gtr:department><gtr:address><gtr:line1>Norwich Research Park</gtr:line1><gtr:line2>Colney</gtr:line2><gtr:postCode>NR4 7UA</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2D8E82C0-85D1-4809-90FC-4716F4AF5865"><gtr:id>2D8E82C0-85D1-4809-90FC-4716F4AF5865</gtr:id><gtr:name>Institute of Food Research</gtr:name><gtr:address><gtr:line1>Norwich Research Park</gtr:line1><gtr:line2>Colney</gtr:line2><gtr:postCode>NR4 7UA</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/90303CCB-A3B5-47D7-9DDA-77CD4ED6BED2"><gtr:id>90303CCB-A3B5-47D7-9DDA-77CD4ED6BED2</gtr:id><gtr:firstName>Maria</gtr:firstName><gtr:surname>Traka</gtr:surname><gtr:orcidId>0000-0002-6592-5691</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BBS%2FE%2FF%2F00044502"><gtr:id>BB73F817-0682-4565-B9AB-A95FD369A5D1</gtr:id><gtr:title>Switching behaviour of PTEN activity</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>BBS/E/F/00044502</gtr:grantReference><gtr:abstractText>Phosphatase and tensin homologue (PTEN), a major tumour suppressor gene, can be inactivated by post-transcriptional modifications (1). PTEN converts phosphatidylinositol (3,4,5)-triphosphate (PIP3) to phosphatidylinositol(4,5)-biphosphate (PIP2), thereby directly opposing the activity of PI3K and downstream phosphorylation of AKT, a major orchestrator of cell growth and cell survival (2). 
Bistability is a fundamental phenomenon in nature and ensures the ?decision? to start the chain of events is ultimate, preventing any non-viable ?half? state (3,4). Analysing a minimal bistable system we have identified three necessary conditions for bistability: a positive feedback, a mechanism to filter out small stimuli and a mechanism to prevent explosions (of concentrations) by a negative feedback (5). We plan to test the hypothesis that high and low PTEN activity corresponds to two clearly distinctive states of cellular behaviour and that the transition from high to low PTEN activity is switch-like rather than linear. We intend to modulate PTEN activity by changing cell redox status, which inactivates PTEN through oxidation of cysteine residues (6,7). This would reflect the increase in oxidative stress seen by ageing and certain lifestyle factors, such as diet and lack of exercise. 
Aim of the project: The aim of this project is to determine whether oxidative stress results in loss of PTEN activity that has the characteristic of a bistable switch. To do this we will devise model(s) of PTEN activity as a result of increasing levels of ROS in healthy prostate cells. We will use SDS-PAGE and HPLC-MS based methods to determine PTEN oxidation status.</gtr:abstractText><gtr:fund><gtr:end>2015-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2014-08-15</gtr:start><gtr:type>EXPENDITURE_PROJECTED</gtr:type><gtr:valuePounds>93713</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">BBS/E/F/00044502</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>